Work

Circulating tumor DNA-based molecular residual disease detection and recurrence monitoring in patients with advanced or metastatic anal squamous cell carcinoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.4_suppl.006

Authors: Georges Azzi, Mehrad Tavallai, Gregory P. Botta, Mohamedtaki Abdulaziz Tejani, Diana L. Hanna, Adham Adel Jurdi, Griffin Budde, Shifra Krinshpun, Minu Maninder, Vasily N. Aushev, Perry Olshan, Paul R. Billings, Alexey Aleshin, Pashtoon Murtaza Kasi

Institutions: Holy Cross Hospital, Natera (United States), University of California San Diego, Moores Cancer Center, University of Rochester Medicine, University of Rochester, Keck Hospital of USC, Omicia (United States), University of Iowa

Language: English

Topic: Colorectal and Anal Carcinomas

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4206715787

Cites:

Cited by:

Related to: 10